Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2017-04-28 Annual Report
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Annual financial report 2016
Annual Report Classification · 100% confidence The document is a comprehensive annual report for 'aap Implantate AG' for the fiscal year 2016. It includes a Table of Contents, a Foreword by the Management Board, a Combined Management Report, and Consolidated Financial Statements (including balance sheets, income statements, and notes). The document length and content confirm it is the full annual report, not an announcement or summary. FY 2016
2017-04-28 English
Annual financial report 2016
Annual Report Classification · 100% confidence The document is a comprehensive annual report for 'aap Implantate AG' for the fiscal year 2016. It includes a Table of Contents, a Foreword by the Management Board, a Combined Management Report, and Consolidated Financial Statements (including balance sheets, income statements, and notes). The document length and content confirm it is the full annual report, not an announcement or summary. FY 2016
2017-04-28 German
aap Implantate AG: 30% sales growth in trauma in the first quarter of 2017
Earnings Release Classification · 100% confidence The document is a news release titled 'aap Implantate AG: 30% sales growth in trauma in the first quarter of 2017' and explicitly mentions 'Preliminary Results/Quarter Results' as keywords. It provides key financial figures (sales for Q1/2017 vs Q1/2016) based on management's initial analysis for the period ended March 31, 2017. It also states that the company plans to publish its *final* results on May 15, 2017. This structure—a brief announcement of preliminary period results before the final report—is characteristic of an Earnings Release (ER). It is not the comprehensive Interim/Quarterly Report (IR) itself, nor is it a full transcript (CT) or a full Annual Report (10-K). Q1 2017
2017-04-24 English
aap Implantate AG: aap concludes distribution agreement for LOQTEQ(R) Radius System with leading US medical technology company
Regulatory Filings Classification · 100% confidence The document is a short news release dated April 21, 2017, announcing that aap Implantate AG has concluded a distribution agreement for a product system with a US medical technology company. It uses keywords like 'DGAP-News', 'Corporate News', and discusses a business alliance/agreement. This type of announcement, which details a significant business development but is not a formal financial report (like 10-K, IR, or ER), fits best under the general Regulatory Filings category (RNS) or potentially a specific business event category if one were available. Since the core content is a business update/alliance announcement, and it is not a financial report, dividend notice, or management change, RNS (Regulatory Filings) serves as the most appropriate general classification for non-standard corporate news disseminated via regulatory channels (DGAP). Given the options, it is a general corporate announcement, not fitting 10-K, ER, MANG, or DIV. RNS is the best fit for general corporate news dissemination.
2017-04-21 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details a "Notification and public disclosure of transactions by persons discharging managerial responsibilities". It lists the name of the individual (Biense Visser), their position (Member of the administrative or supervisory body), the nature of the transaction (Acquisition), the price, volume, and date of the transaction involving shares of aap Implantate AG. This content directly matches the definition for Director's Dealing.
2017-04-13 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It details the name of the person (Biense Visser), their position (Member of the administrative or supervisory body), the nature of the transaction (Acquisition), the price, volume, and date of the transaction involving shares of aap Implantate AG. This directly corresponds to the definition of Director's Dealing.
2017-04-10 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.